procarbazine has been researched along with B-Cell Lymphoma in 25 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Erythema nodosum is the most frequent clinicopathological variant of the panniculitides." | 2.42 | [Erythema nodosum association with malignant lymphoma]. ( Griniūte, R; Pileckyte, M, 2003) |
| "Acquired ichthyosis is a rare condition that can reveal an unsuspected haematological malignancy, thus allowing early diagnosis and management." | 1.38 | [Acquired ichthyosis and haematological malignancies: five cases]. ( Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ, 2012) |
| "Grade 3 follicular lymphoma (FL3) is thought to have an aggressive clinical course." | 1.32 | A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. ( Aoun, P; Armitage, JO; Bierman, PJ; Bociek, RG; Chan, WC; Greiner, TC; Hans, CP; Hock, LM; Lynch, JC; Vose, JM; Weisenburger, DD, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (32.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lian, K | 3 |
| Zhang, QH | 3 |
| Hou, SL | 3 |
| Li, L | 3 |
| Aoki, H | 1 |
| Ogura, R | 1 |
| Tsukamoto, Y | 1 |
| Okada, M | 1 |
| Natsumeda, M | 1 |
| Isogawa, M | 1 |
| Yoshida, S | 1 |
| Fujii, Y | 1 |
| Sangave, A | 1 |
| Faia, LJ | 1 |
| Yeh, S | 1 |
| Chan, CC | 1 |
| Nussenblatt, RB | 1 |
| Sen, HN | 1 |
| Kharfan-Dabaja, MA | 1 |
| Cutler, CS | 1 |
| Berrady, R | 1 |
| Baybay, H | 1 |
| Khammar, Z | 1 |
| Lahlou, M | 1 |
| Lamchachti, L | 1 |
| Gallouj, S | 1 |
| El Hatimi, A | 1 |
| Mernissi, FZ | 1 |
| Bono, W | 1 |
| Hans, CP | 1 |
| Weisenburger, DD | 1 |
| Vose, JM | 1 |
| Hock, LM | 1 |
| Lynch, JC | 1 |
| Aoun, P | 1 |
| Greiner, TC | 1 |
| Chan, WC | 2 |
| Bociek, RG | 1 |
| Bierman, PJ | 1 |
| Armitage, JO | 1 |
| Au, WY | 1 |
| Ma, SK | 1 |
| Wan, TS | 1 |
| Wang, EP | 1 |
| Lau, TC | 1 |
| Kwong, YL | 1 |
| Pileckyte, M | 1 |
| Griniūte, R | 1 |
| Lee, KW | 1 |
| Kim, DY | 1 |
| Yun, T | 1 |
| Kim, DW | 1 |
| Kim, TY | 1 |
| Yoon, SS | 1 |
| Heo, DS | 1 |
| Bang, YJ | 1 |
| Park, S | 1 |
| Kim, BK | 1 |
| Kim, NK | 1 |
| Schneider, T | 1 |
| Tóth, E | 1 |
| Molnár, Z | 1 |
| Várady, E | 1 |
| Deák, B | 1 |
| Horváth, A | 1 |
| Horváth, GI | 1 |
| Eid, H | 1 |
| Schneider, K | 1 |
| Lovey, J | 1 |
| Keresztes, S | 1 |
| Esik, O | 1 |
| Lengyel, Z | 1 |
| Rosta, A | 1 |
| Herrlinger, U | 1 |
| Hebart, H | 1 |
| Kanz, L | 1 |
| Dichgans, J | 1 |
| Weller, M | 1 |
| Jones, R | 1 |
| Kirkup, M | 1 |
| Guglani, S | 1 |
| Hopkins, K | 1 |
| Kober, T | 1 |
| Hülsewede, H | 1 |
| Bohlius, J | 1 |
| Engert, A | 1 |
| Partap, S | 1 |
| Spence, AM | 1 |
| Niitsu, N | 2 |
| Umeda, M | 2 |
| Arai, N | 2 |
| Shirai, T | 2 |
| Rysenga, E | 1 |
| Linden, MD | 1 |
| Carey, JL | 1 |
| Ross, CW | 1 |
| Schnitzer, B | 1 |
| Sawdyk, M | 1 |
| Maeda, K | 1 |
| Ohno, T | 1 |
| Trenn, G | 1 |
| Wu, G | 1 |
| Abou-Elella, A | 1 |
| Reis, HE | 1 |
| Krackhardt, A | 1 |
| Schwartz, S | 1 |
| Korfel, A | 1 |
| Thiel, E | 1 |
| Abrey, LE | 1 |
| Yahalom, J | 1 |
| DeAngelis, LM | 1 |
| Iijima, K | 1 |
| Chizuka, A | 1 |
| Kirchner, EM | 1 |
| Ebsen, M | 1 |
| Kirchner, J | 1 |
| Theegarten, D | 1 |
| Voigtmann, R | 1 |
| Wada, S | 1 |
| Kitamura, H | 1 |
| Matsuura, Y | 1 |
| Katayama, Y | 1 |
| Ohkawa, H | 1 |
| Kugai, N | 1 |
| Motoyoshi, K | 1 |
| Fuse, Y | 1 |
| Nagata, N | 1 |
| Hara, A | 1 |
| Liang, R | 1 |
| Chiu, E | 1 |
| Chan, TK | 1 |
| Todd, D | 1 |
| Loke, SL | 1 |
4 reviews available for procarbazine and B-Cell Lymphoma
| Article | Year |
|---|---|
Rituximab for prevention and treatment of graft-versus-host disease.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2011 |
[Erythema nodosum association with malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Dif | 2003 |
Fourth biannual report of the Cochrane Haematological Malignancies Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2006 |
[Massive bilateral non-Hodgkin's lymphoma of the adrenal glands].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1990 |
1 trial available for procarbazine and B-Cell Lymphoma
| Article | Year |
|---|---|
Treatment for primary CNS lymphoma: the next step.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2000 |
20 other studies available for procarbazine and B-Cell Lymphoma
| Article | Year |
|---|---|
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurr | 2023 |
Advantages of dose-dense methotrexate protocol for primary central nervous system lymphoma: comparison of two different protocols at a single institution.
Topics: Academies and Institutes; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic C | 2013 |
A case of rapid progression and vision loss in a patient with primary intraocular lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Disease Progression; Eye Neoplasms; | 2010 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Ant | 2012 |
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2003 |
Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clone Cells; Combined Modal | 2003 |
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy P | 2003 |
[Treatment of primary mediastinal large B-cell lymphomas].
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleo | 2004 |
Relapse of primary CNS lymphoma after more than 10 years in complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Mo | 2005 |
Toxic epidermal necrolysis after PCV combination chemotherapy for relapsed B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Humans; Lomustine; Lymphoma, B-Cell | 2006 |
Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Central Nervous System Neop | 2006 |
[3 cases of elderly malignant lymphoma of the thyroid gland].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1994 |
[Evaluation of bronchoalveolar lavage fluid in patients with B-cell lymphoma before and after COP-BLAM therapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronch | 1993 |
Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphocytes; Lymphoma, B-Ce | 1995 |
The clonal relationship between nodular sclerosis Hodgkin's disease with a clonal Reed-Sternberg cell population and a subsequent B-cell small noncleaved cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Cycloph | 1998 |
Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.
Topics: Acute Kidney Injury; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pro | 1999 |
A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2001 |
Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2001 |
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol | 1992 |
Direct comparison of peripheral T-cell lymphomas with their B-cell counterpart.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Cyclophosphamide; Dexamethasone; D | 1991 |